Life's shareholders sign off on Thermo Fisher's $13.6B bid; AtriCure expands Japan distribution deal;

@FierceMedDev: Infraredx snags $25M as it sets sights on Japan. News | Follow @FierceMedDev

@DamianFierce: Bard settled another vaginal mesh lawsuit. That leaves about 7,999 to go. News | Follow @DamianFierce

@MarkHFierce: Why does Medtronic CEO Omar Ishrak tweet? Editor's corner | Follow @MarkHFierce

@MichaelGFierce: ICYMI... Study: Insulin pumps improve glycemic control in children with diabetes. Article | Follow @MichaelGFierce

> Life Technologies ($LIFE) has successfully convinced its shareholders to accept Thermo Fisher's ($TMO) $13.6 billion takeover bid. News

> AtriCure ($ATRC) has expanded its distribution deal with Japan's Century Medical, giving local Century rights to more of AtriCutre's cardiac devices. More

> Navidea Biopharmaceuticals ($NAVB) secured the FDA's blessing to switch up the endpoints of its Phase III trial of NAV5001, an imaging agent designed to identify Parkinson's disease. Item

> California's Eclipse Breast Health is going the crowdfunding route to develop its hand-held imaging device, seeking $650,000 on Indiegogo. Story

> The FDA has embraced 3-D printing technology, using it in research and evaluation of medical devices. Blog post

> Imaging company VirtualScopics ($VSCP) will pursue a 1-for-10 reverse stock split. Item

> SomaLogic, a company focused, in part, on clinical diagnostics, has raised $10 million in equity financing. Item (reg. req.)

> Rinovum Women's Health gained a CE mark for a cervical-cap conception device designed to assist couples struggling with fertility. Story

Biotech News

@FierceBiotech: Popular yesterday: Incyte shares soar on positive pancreatic cancer trial data for Jakafi. Article | Follow @FierceBiotech

@JohnCFierce: FYI, we're adding a weekly diagnostics report to go along with our fast-growing med devices group of pubs. End of the month. Look for it. | Follow @JohnCFierce

@EmilyMFierce: Sodium 'switch' could provide target to treat brain disorders. Item | Follow @EmilyMFierce

> Analyst: Time to wrap up Amgen's $9.5B Onyx buyout. Story

> Regado misses IPO fiesta, limps into public spotlight with $43M raise. Article

> U.S./China biotech hybrid lands $25M to back global R&D strategy. Report

Pharma News

@FiercePharma: China's pharma probe intensifies with British consultant's arrest. ICYMI yesterday | Follow @FiercePharma

@CarlyHFierce: Check out Eli Lilly's statement on the latest bribery allegations in China. Article | Follow @CarlyHFierce

> Teva chairman defends CEO Levin from fed-up analysts. More

> Amid Purdue criticism, CVS cuts opioid access for 'risky' prescribers. Story

> Onyx hands bidders new Kyprolis data to smooth path to $9.5B deal. Report

Vaccines News

> Sanofi delays return of vaccines after testing 'anomaly.' More

> GSK-backed study links flu vaccine to lower risk of heart attack. Report

> Improved vaccines mean flu immunization can start earlier. Story

> Vaccine refusers to miss out on tax benefits under Australian plan. Article

> India to investigate safety of pentavalent vaccines. More

Pharma Manufacturing News

@EricPFierce: Regeneron will turn an empty Dell computer plant in Ireland into its second manufacturing plant. Article | Follow @EricPFierce

> Dr. Reddy's recall affects Walmart, Walgreens, Supervalu. Item

> Doxycycline shortage shot in the arm for Hikma profits. More

> FDA not alone in acting on compounding pharmacies. Article

> Fresenius Kabi expands manufacturing in Indonesia with JV. Story

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.